Merck (MRK) Retained Earnings (2009 - 2026)

Merck has disclosed Retained Earnings across 18 years of filings, most recently posting $66.7 billion for Q1 2026.

• In Q1 2026, Retained Earnings rose 1443.83% year-over-year to $66.7 billion; the TTM figure through Mar 2026 stood at $66.7 billion (up 1443.83% YoY), while the FY2025 annual figure was $73.1 billion, up 1577.76% from the prior year.
• Retained Earnings eased to $66.7 billion in Q1 2026, from $73.1 billion in the prior quarter.
• Over the last five years, Retained Earnings for MRK reached as high as $73.1 billion in Q4 2025 and fell as low as -$5.4 billion in Q2 2024.
• The 5-year median for Retained Earnings is $56.3 billion (2022), against an average of $38.4 billion.
• Annual changes were most pronounced in 2024 — Retained Earnings tumbled 109.89% — and 2025, when it jumped 1577.76%.
• A 5-year view of Retained Earnings shows it stood at $61.1 billion in 2022, then slipped by 11.76% to $53.9 billion in 2023, then tumbled by 109.18% to -$4.9 billion in 2024, then soared by 1577.76% to $73.1 billion in 2025, then slipped by 8.7% to $66.7 billion in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered $66.7 billion, $73.1 billion, and $72.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.